ConductScience.org, home

Paper26317460

DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension.

Licht JD. Cell, 2015. Cited by 53 papers, by iCite.

Cite this record

ConductScience Library. DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension. Papers, record 26317460. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26317460

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension.
PubMed
Journal
Cell
PubMed
Year
2015
PubMed
Publication types
Journal Article, Comment
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
1.25
iCite
Revised in PubMed
2018-12-02
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Licht JDJonathan D

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antimetabolites, AntineoplasticMajor topic
AzacitidineMajor topic
Colorectal NeoplasmsMajor topic
DNA MethylationMajor topic
Interferon Type IMajor topic
MelanomaMajor topic
Animals
Female
Humans

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
U54 CA193419NCI NIH HHSUnited StatesU54CA193419PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment on26317465DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts.https://conductscience.org/library/papers/26317465PubMed
Comment on26317466Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.https://conductscience.org/library/papers/26317466PubMed

Download CSV of comments and corrections

Cited by40

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
41582215Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications.Signal Transduct Target Ther2026https://conductscience.org/library/papers/41582215PubMed
41190324A novel mechanism by which c-MYC is aberrantly activated by epigenetic silencing of its antisense lncRNA in colon cancer.Front Genet2025https://conductscience.org/library/papers/41190324PubMed
40352490Recent Advances in Therapeutic Peptides: Innovations and Applications in Treating Infections and Diseases.ACS Omega2025https://conductscience.org/library/papers/40352490PubMed
38554170Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement.Mol Divers2024https://conductscience.org/library/papers/38554170PubMed
37543704Transposable elements potentiate radiotherapy-induced cellular immune reactions via RIG-I-mediated virus-sensing pathways.Commun Biol2023https://conductscience.org/library/papers/37543704PubMed
36660694Value of genomics- and radiomics-based machine learning models in the identification of breast cancer molecular subtypes: a systematic review and meta-analysis.Ann Transl Med2022https://conductscience.org/library/papers/36660694PubMed
36350516The Role of DNA Methylation and DNA Methyltransferases in Cancer.Adv Exp Med Biol2022https://conductscience.org/library/papers/36350516PubMed
36324900Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs.Front Bioeng Biotechnol2022https://conductscience.org/library/papers/36324900PubMed
36213536Carbohydrate-based drugs launched during 2000-2021.Acta Pharm Sin B2022https://conductscience.org/library/papers/36213536PubMed
35836879A systematic pan-cancer analysis identifies RIOK3 as an immunological and prognostic biomarker.Am J Transl Res2022https://conductscience.org/library/papers/35836879PubMed
35715584Activation of lnc-ALVE1-AS1 inhibited ALV-J replication through triggering the TLR3 pathway in chicken macrophage like cell line.Vet Res Commun2023https://conductscience.org/library/papers/35715584PubMed
35693795Epigenetics Regulates Antitumor Immunity in Melanoma.Front Immunol2022https://conductscience.org/library/papers/35693795PubMed
34586646DNA hypomethylation leads to cGAS-induced autoinflammation in the epidermis.EMBO J2021https://conductscience.org/library/papers/34586646PubMed
33980308
Echinacea purpurea (L.) Moench treatment of monocytes promotes tonic interferon signaling, increased innate immunity gene expression and DNA repeat hypermethylated silencing of endogenous retroviral sequences.
BMC Complement Med Ther2021https://conductscience.org/library/papers/33980308PubMed
33669837Changes in Apoptotic Pathways in MOLM-13 Cell Lines after Induction of Resistance to Hypomethylating Agents.Int J Mol Sci2021https://conductscience.org/library/papers/33669837PubMed
33584800Decitabine Induces Change of Biological Traits in Myelodysplastic Syndromes via FOXO1 Activation.Front Genet2020https://conductscience.org/library/papers/33584800PubMed
32252665The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancers.BMC Cancer2020https://conductscience.org/library/papers/32252665PubMed
31646020Effective demethylation of melanoma cells using terahertz radiation.Biomed Opt Express2019https://conductscience.org/library/papers/31646020PubMed
31612060Diagnostic and prognostic value of the BEX family in lung adenocarcinoma.Oncol Lett2019https://conductscience.org/library/papers/31612060PubMed
31357729DNA Methylation Module Network-Based Prognosis and Molecular Typing of Cancer.Genes (Basel)2019https://conductscience.org/library/papers/31357729PubMed

See all 40 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26317460

GET https://conductscience.org/api/papers/v1/26317460/cited_by?page=2